BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31522426)

  • 41. [Characteristics and clinical significance of immunophenotype in chronic lymphocytic leukemia].
    Kuang WY; Zhang GS; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):662-6. PubMed ID: 16114552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of a novel eight-color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia.
    Chen X; Chen X; Zhao S; Shi Y; Zhang N; Guo Z; Qiao C; Jin H; Zhu L; Zhu H; Li J; Wu Y
    Cytometry B Clin Cytom; 2024 May; 106(3):181-191. PubMed ID: 38535092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunophenotypic and cytogenetic features in 51 cases of chronic lymphocytic leukemia].
    Ma QF; Zhou HF; Zhu MQ; Liu DD; Chen ZX; Xue YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):696-9. PubMed ID: 17708785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunophenotypic characterization of normal peripheral blood B lymphocyte by flow cytometry: reference for diagnosis of chronic B cell leukemia/lymphoma.
    Zheng ZJ; Xu RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):398-404. PubMed ID: 12962571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal/Measurable Disease Analysis in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Flow Cytometry.
    Gao Q; Roshal M
    Curr Protoc; 2022 Aug; 2(8):e503. PubMed ID: 35980134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of a scoring system for diagnosis of chronic lymphocytic leukemia in Thai patients.
    Promsuwicha O; Songmuang W; Auewarakul CU
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S232-8. PubMed ID: 21721452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
    Rawstron AC; Fazi C; Agathangelidis A; Villamor N; Letestu R; Nomdedeu J; Palacio C; Stehlikova O; Kreuzer KA; Liptrot S; O'Brien D; de Tute RM; Marinov I; Hauwel M; Spacek M; Dobber J; Kater AP; Gambell P; Soosapilla A; Lozanski G; Brachtl G; Lin K; Boysen J; Hanson C; Jorgensen JL; Stetler-Stevenson M; Yuan C; Broome HE; Rassenti L; Craig F; Delgado J; Moreno C; Bosch F; Egle A; Doubek M; Pospisilova S; Mulligan S; Westerman D; Sanders CM; Emerson R; Robins HS; Kirsch I; Shanafelt T; Pettitt A; Kipps TJ; Wierda WG; Cymbalista F; Hallek M; Hillmen P; Montserrat E; Ghia P
    Leukemia; 2016 Apr; 30(4):929-36. PubMed ID: 26639181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
    McCarron KF; Hammel JP; Hsi ED
    Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    Jalal SD
    PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.
    Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN
    Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
    Stehlíková O; Chovancová J; Tichý B; Krejčí M; Brychtová Y; Panovská A; Francová Skuhrová H; Burčková K; Borský M; Loja T; Mayer J; Pospíšilová S; Doubek M
    Int J Lab Hematol; 2014 Apr; 36(2):165-71. PubMed ID: 24028768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.